Global Clinical Oncology Next Generation Sequencing (NGS) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
SCOPE OF THE REPORT:
This report studies the Clinical Oncology Next Generation Sequencing (NGS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Clinical Oncology Next Generation Sequencing (NGS) market by product type and applications/end industries.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
The global Clinical Oncology Next Generation Sequencing (NGS) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Clinical Oncology Next Generation Sequencing (NGS).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
This report studies the Clinical Oncology Next Generation Sequencing (NGS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Clinical Oncology Next Generation Sequencing (NGS) market by product type and applications/end industries.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
The global Clinical Oncology Next Generation Sequencing (NGS) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Clinical Oncology Next Generation Sequencing (NGS).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Illumina
- Roche
- Agilent Technologies
- Knome
- Genomatix Software
- GATC Biotech
- Oxford Nanopore Technologies
- Macrogen
- Life Technologies
- DNASTAR
- Exosome Diagnostics
- Biomatters
- CLC Bio
- BGI
- Qiagen
- Perkin Elmer
- Pacific Bioscience
- Partek
- GnuBIO
- Foundation Medicine
- Paradigm
- Caris Life Sciences
- Myriad Genetics
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- NGS Pre-Sequencing
- Sequencing
- NGS Data Analysis
- Primary, Secondary & Tertiary Data Analysis
- Academic & Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
1 CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET OVERVIEW
1.1 Product Overview and Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Classification of Clinical Oncology Next Generation Sequencing (NGS) by Types
1.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Comparison by Types (2017-2023)
1.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Types in 2017
1.2.3 NGS Pre-Sequencing
1.2.4 Sequencing
1.2.5 NGS Data Analysis
1.2.6 Primary, Secondary & Tertiary Data Analysis
1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Application
1.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Academic & Clinical Research
1.3.3 Hospitals & Clinics
1.3.4 Pharma & Biotech Entities
1.4 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Regions
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.5 Global Market Size of Clinical Oncology Next Generation Sequencing (NGS) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Illumina
2.1.1 Business Overview
2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Knome
2.4.1 Business Overview
2.4.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genomatix Software
2.5.1 Business Overview
2.5.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.6 GATC Biotech
2.6.1 Business Overview
2.6.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Oxford Nanopore Technologies
2.7.1 Business Overview
2.7.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Macrogen
2.8.1 Business Overview
2.8.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Life Technologies
2.9.1 Business Overview
2.9.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.10 DNASTAR
2.10.1 Business Overview
2.10.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Exosome Diagnostics
2.11.1 Business Overview
2.11.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.12 Biomatters
2.12.1 Business Overview
2.12.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.13 CLC Bio
2.13.1 Business Overview
2.13.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.14 BGI
2.14.1 Business Overview
2.14.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.15 Qiagen
2.15.1 Business Overview
2.15.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.16 Perkin Elmer
2.16.1 Business Overview
2.16.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pacific Bioscience
2.17.1 Business Overview
2.17.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.18 Partek
2.18.1 Business Overview
2.18.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.19 GnuBIO
2.19.1 Business Overview
2.19.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.20 Foundation Medicine
2.20.1 Business Overview
2.20.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.21 Paradigm
2.21.1 Business Overview
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.22 Caris Life Sciences
2.22.1 Business Overview
2.22.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.23 Myriad Genetics
2.23.1 Business Overview
2.23.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITION, BY PLAYERS
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Oncology Next Generation Sequencing (NGS) Players Market Share
3.2.2 Top 10 Clinical Oncology Next Generation Sequencing (NGS) Players Market Share
3.3 Market Competition Trend
4 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY REGIONS
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Market Share by Regions
4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.5 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
5.1 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
5.2 USA Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5.3 Canada Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5.4 Mexico Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6 EUROPE CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
6.2 Germany Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.3 UK Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.4 France Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.5 Russia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.6 Italy Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
7.1 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
7.2 China Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.4 Korea Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.5 India Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
8.1 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
8.2 Brazil Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8.3 Argentina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8.4 Colombia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY COUNTRIES
9.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.3 UAE Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.4 Egypt Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.6 South Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
10 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENT BY TYPE
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Market Share by Type (2013-2018)
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2018-2023)
10.3 NGS Pre-Sequencing Revenue Growth Rate (2013-2023)
10.4 Sequencing Revenue Growth Rate (2013-2023)
10.5 NGS Data Analysis Revenue Growth Rate (2013-2023)
10.6 Primary, Secondary & Tertiary Data Analysis Revenue Growth Rate (2013-2023)
11 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENT BY APPLICATION
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application (2013-2018)
11.2 Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2018-2023)
11.3 Academic & Clinical Research Revenue Growth (2013-2018)
11.4 Hospitals & Clinics Revenue Growth (2013-2018)
11.5 Pharma & Biotech Entities Revenue Growth (2013-2018)
12 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE FORECAST (2018-2023)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Regions (2018-2023)
12.3 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.6 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Clinical Oncology Next Generation Sequencing (NGS)
1.2 Classification of Clinical Oncology Next Generation Sequencing (NGS) by Types
1.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Comparison by Types (2017-2023)
1.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Types in 2017
1.2.3 NGS Pre-Sequencing
1.2.4 Sequencing
1.2.5 NGS Data Analysis
1.2.6 Primary, Secondary & Tertiary Data Analysis
1.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Application
1.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Academic & Clinical Research
1.3.3 Hospitals & Clinics
1.3.4 Pharma & Biotech Entities
1.4 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Regions
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Clinical Oncology Next Generation Sequencing (NGS) Status and Prospect (2013-2023)
1.5 Global Market Size of Clinical Oncology Next Generation Sequencing (NGS) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Illumina
2.1.1 Business Overview
2.1.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Agilent Technologies
2.3.1 Business Overview
2.3.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Knome
2.4.1 Business Overview
2.4.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genomatix Software
2.5.1 Business Overview
2.5.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.6 GATC Biotech
2.6.1 Business Overview
2.6.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Oxford Nanopore Technologies
2.7.1 Business Overview
2.7.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Macrogen
2.8.1 Business Overview
2.8.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Life Technologies
2.9.1 Business Overview
2.9.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.10 DNASTAR
2.10.1 Business Overview
2.10.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Exosome Diagnostics
2.11.1 Business Overview
2.11.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.12 Biomatters
2.12.1 Business Overview
2.12.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.13 CLC Bio
2.13.1 Business Overview
2.13.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.14 BGI
2.14.1 Business Overview
2.14.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.15 Qiagen
2.15.1 Business Overview
2.15.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.16 Perkin Elmer
2.16.1 Business Overview
2.16.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pacific Bioscience
2.17.1 Business Overview
2.17.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.18 Partek
2.18.1 Business Overview
2.18.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.19 GnuBIO
2.19.1 Business Overview
2.19.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.20 Foundation Medicine
2.20.1 Business Overview
2.20.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.21 Paradigm
2.21.1 Business Overview
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.22 Caris Life Sciences
2.22.1 Business Overview
2.22.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
2.23 Myriad Genetics
2.23.1 Business Overview
2.23.2 Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET COMPETITION, BY PLAYERS
3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Clinical Oncology Next Generation Sequencing (NGS) Players Market Share
3.2.2 Top 10 Clinical Oncology Next Generation Sequencing (NGS) Players Market Share
3.3 Market Competition Trend
4 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE BY REGIONS
4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Market Share by Regions
4.2 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.3 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.5 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
5.1 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
5.2 USA Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5.3 Canada Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
5.4 Mexico Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6 EUROPE CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
6.1 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
6.2 Germany Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.3 UK Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.4 France Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.5 Russia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
6.6 Italy Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
7.1 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
7.2 China Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.3 Japan Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.4 Korea Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.5 India Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) REVENUE BY COUNTRIES
8.1 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
8.2 Brazil Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8.3 Argentina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
8.4 Colombia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) BY COUNTRIES
9.1 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.3 UAE Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.4 Egypt Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
9.6 South Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
10 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENT BY TYPE
10.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue and Market Share by Type (2013-2018)
10.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Type (2018-2023)
10.3 NGS Pre-Sequencing Revenue Growth Rate (2013-2023)
10.4 Sequencing Revenue Growth Rate (2013-2023)
10.5 NGS Data Analysis Revenue Growth Rate (2013-2023)
10.6 Primary, Secondary & Tertiary Data Analysis Revenue Growth Rate (2013-2023)
11 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SEGMENT BY APPLICATION
11.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Application (2013-2018)
11.2 Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Application (2018-2023)
11.3 Academic & Clinical Research Revenue Growth (2013-2018)
11.4 Hospitals & Clinics Revenue Growth (2013-2018)
11.5 Pharma & Biotech Entities Revenue Growth (2013-2018)
12 GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING (NGS) MARKET SIZE FORECAST (2018-2023)
12.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Forecast (2018-2023)
12.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market Forecast by Regions (2018-2023)
12.3 North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.4 Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.6 South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Clinical Oncology Next Generation Sequencing (NGS) Picture
Table Product Specifications of Clinical Oncology Next Generation Sequencing (NGS)
Table Global Clinical Oncology Next Generation Sequencing (NGS) and Revenue (Million USD) Market Split by Product Type
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Types in 2017
Figure NGS Pre-Sequencing Picture
Figure Sequencing Picture
Figure NGS Data Analysis Picture
Figure Primary, Secondary & Tertiary Data Analysis Picture
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Application (2013-2023)
Figure Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Applications in 2017
Figure Academic & Clinical Research Picture
Figure Hospitals & Clinics Picture
Figure Pharma & Biotech Entities Picture
Table Global Market Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Knome Basic Information, Manufacturing Base and Competitors
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Genomatix Software Basic Information, Manufacturing Base and Competitors
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table GATC Biotech Basic Information, Manufacturing Base and Competitors
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Oxford Nanopore Technologies Basic Information, Manufacturing Base and Competitors
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Macrogen Basic Information, Manufacturing Base and Competitors
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Life Technologies Basic Information, Manufacturing Base and Competitors
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table DNASTAR Basic Information, Manufacturing Base and Competitors
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Exosome Diagnostics Basic Information, Manufacturing Base and Competitors
Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Biomatters Basic Information, Manufacturing Base and Competitors
Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table CLC Bio Basic Information, Manufacturing Base and Competitors
Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Perkin Elmer Basic Information, Manufacturing Base and Competitors
Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Pacific Bioscience Basic Information, Manufacturing Base and Competitors
Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Partek Basic Information, Manufacturing Base and Competitors
Table Partek Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table GnuBIO Basic Information, Manufacturing Base and Competitors
Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Paradigm Basic Information, Manufacturing Base and Competitors
Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Players (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players in 2016
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players in 2017
Figure Global Top 5 Players Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share in 2017
Figure Global Top 10 Players Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share in 2017
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Regions (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions in 2017
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table North America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
Table North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure USA Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure China Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table South America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
Table South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Argentina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Colombia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure UAE Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Nigeria Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Forecast by Type (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2018-2023)
Figure Global NGS Pre-Sequencing Revenue Growth Rate (2013-2018)
Figure Global Sequencing Revenue Growth Rate (2013-2018)
Figure Global NGS Data Analysis Revenue Growth Rate (2013-2018)
Figure Global Primary, Secondary & Tertiary Data Analysis Revenue Growth Rate (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Application (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Forecast by Application (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2018-2023)
Figure Global Academic & Clinical Research Revenue Growth Rate (2013-2018)
Figure Global Hospitals & Clinics Revenue Growth Rate (2013-2018)
Figure Global Pharma & Biotech Entities Revenue Growth Rate (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Clinical Oncology Next Generation Sequencing (NGS) Picture
Table Product Specifications of Clinical Oncology Next Generation Sequencing (NGS)
Table Global Clinical Oncology Next Generation Sequencing (NGS) and Revenue (Million USD) Market Split by Product Type
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Types in 2017
Figure NGS Pre-Sequencing Picture
Figure Sequencing Picture
Figure NGS Data Analysis Picture
Figure Primary, Secondary & Tertiary Data Analysis Picture
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Application (2013-2023)
Figure Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Applications in 2017
Figure Academic & Clinical Research Picture
Figure Hospitals & Clinics Picture
Figure Pharma & Biotech Entities Picture
Table Global Market Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (2013-2023)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Knome Basic Information, Manufacturing Base and Competitors
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Genomatix Software Basic Information, Manufacturing Base and Competitors
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table GATC Biotech Basic Information, Manufacturing Base and Competitors
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Oxford Nanopore Technologies Basic Information, Manufacturing Base and Competitors
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Macrogen Basic Information, Manufacturing Base and Competitors
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Macrogen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Life Technologies Basic Information, Manufacturing Base and Competitors
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table DNASTAR Basic Information, Manufacturing Base and Competitors
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Exosome Diagnostics Basic Information, Manufacturing Base and Competitors
Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Biomatters Basic Information, Manufacturing Base and Competitors
Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table CLC Bio Basic Information, Manufacturing Base and Competitors
Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table BGI Basic Information, Manufacturing Base and Competitors
Table BGI Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Perkin Elmer Basic Information, Manufacturing Base and Competitors
Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Pacific Bioscience Basic Information, Manufacturing Base and Competitors
Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Partek Basic Information, Manufacturing Base and Competitors
Table Partek Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Partek Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table GnuBIO Basic Information, Manufacturing Base and Competitors
Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Foundation Medicine Basic Information, Manufacturing Base and Competitors
Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Paradigm Basic Information, Manufacturing Base and Competitors
Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Caris Life Sciences Basic Information, Manufacturing Base and Competitors
Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Type and Applications
Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Players (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players in 2016
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Players in 2017
Figure Global Top 5 Players Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share in 2017
Figure Global Top 10 Players Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share in 2017
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Regions (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Regions in 2017
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table North America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
Table North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure USA Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Canada Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Mexico Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Germany Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure UK Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure France Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Russia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Italy Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure China Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Japan Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Korea Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure India Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table South America Clinical Oncology Next Generation Sequencing (NGS) Revenue by Countries (2013-2018)
Table South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Brazil Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Argentina Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Colombia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure UAE Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Egypt Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure Nigeria Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Figure South Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue and Growth Rate (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) by Type (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Type in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Forecast by Type (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Type (2018-2023)
Figure Global NGS Pre-Sequencing Revenue Growth Rate (2013-2018)
Figure Global Sequencing Revenue Growth Rate (2013-2018)
Figure Global NGS Data Analysis Revenue Growth Rate (2013-2018)
Figure Global Primary, Secondary & Tertiary Data Analysis Revenue Growth Rate (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Application (2013-2018)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Share by Application in 2017
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Forecast by Application (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Market Share Forecast by Application (2018-2023)
Figure Global Academic & Clinical Research Revenue Growth Rate (2013-2018)
Figure Global Hospitals & Clinics Revenue Growth Rate (2013-2018)
Figure Global Pharma & Biotech Entities Revenue Growth Rate (2013-2018)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Clinical Oncology Next Generation Sequencing (NGS) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Europe Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure South America Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Clinical Oncology Next Generation Sequencing (NGS) Revenue Market Forecast (2018-2023)
